Nestle will launch a line of high-protein and fiber foods aimed at those taking Ozempic or Wegovy for weight management, the ...

Only 14.5% of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen ...

While Eli Lilly and Novo Nordisk currently dominate the GLP-1 receptor agonist space, there are more than 50 candidates in ...

Research shows that a new test that assigns a genetic risk score to patients may be able to spot who is likely to be ...

Nestlé is the latest company to join the lucrative world of Ozempic. It’s launching a new line of frozen food created with users of GLP-1 agonist medications in mind.

Hims & Hers aims to capitalize on the shortages of the branded drugs Wegovy and Zepbound. Read more to see why I'm bullish on ...

Persons with asthma or COPD found through community outreach had improvements in lung function and quality of life over 1 year in a randomized trial.

One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, ...

Weight loss drugs such as Ozempic and Wegovy are drawing a growing number of lawsuits, as patients accuse the drug ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of incretin mimetic medicines for the treatment of Type 2 ...

Glucagon-like peptide-1 agonist drugs have been surging in popularity, and manufacturers are scurrying to keep up with demand. Overall, the GLP-1 market is expected to experience annual growth ...

For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill their prescriptions for the medications they need to control their blood ...